SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Contract Win

24 Aug 2010 07:00

INTERSERVE APPOINTED TO £4.5bn PROCURE21+ NHS FRAMEWORK AGREEMENT

Interserve, the international services, maintenance and building group, has been named as one of the six Principal Supply Chain Partners (PCSPs) in the new ProCure21+ framework agreement, estimated to be worth up to £4.5 billion over its six-year term.

ProCure21+ will begin operating on 1st October 2010. It is a new framework that will replace the current ProCure21 programme through which Interserve has undertaken 136 schemes on behalf of 52 NHS Trusts since its pilot in 2002. Like ProCure21 the framework will streamline and improve the procurement process for NHS Trusts across England. This will enable them to select an appropriate supply chain partner to deliver acute, primary care and mental health facilities. As with ProCure21, there is a commitment to long-term relationships, collaborative working, integrated supply chains and the use of target-cost contracts.

There are a number of new features in ProCure21+ including:

* A centrally-provided risk evaluation tool for all schemes to improve

consistency and share approaches to managing common risks.

* A central repository of technical drawings and information that can be

re-used by all clients and supply-chain members under the "NHS Royalty-Free

Licence".

* An online "monthly monitoring" performance management system with a reduced

benchmarking data set to manage scheme performance centrally.

* Provision of a project start-up workshop by PCSPs on all schemes to align

stakeholder and supply chain requirements early in the process.

* Assurance of a VAT-compliant PSCP structure to maximise VAT recovery for

NHS Clients.

Commenting on Interserve's selection as a Principal Supply Chain Partner, Adrian Ringrose, Chief Executive, said, "The creation of ProCure21+ is excellent news. Under ProCure21 Interserve has been able to deliver many high-quality, value-for-money facilities and ProCure21+ will enable us to continue enhancing the health environment to meet the changing needs of the NHS. We are well positioned to do this as the only Health Framework Partner supporting the NHS across England, Scotland and Wales."

- Ends -

For further information please contact:

Amanda Cardall 0121 331 8125 Corporate Marketing Manager Elizabeth Morley / Tom Eckersley 020 7379 5151

Maitland About Interserve

Over the last five years Interserve has delivered healthcare projects with a total value of approximately £500 million, most of which has been through ProCure21.

Interserve's vision is to be the Trusted Partner of all our stakeholders. We are one of the world's foremost support services and construction companies, operating in the public and private sectors in the UK and internationally. We offer advice, design, construction and facilities management services for society's infrastructure and provide a range of plant and equipment in specialist fields. Interserve is based in the UK. It has revenue of £1.9 billion and a workforce of 50,000 people worldwide.

Health website: www.health.interserve.com

General website: www.interserve.com.

vendor
Date   Source Headline
20th Jan 20099:52 amPRNHolding(s) in Company
14th Jan 20097:00 amPRNRe Contract
14th Jan 20097:00 amPRNTrading Statement
2nd Jan 20099:00 amPRNBlocklisting - Interim Review
18th Dec 20088:56 amPRNDirector Declaration
18th Dec 20088:48 amPRNHolding(s) in Company
16th Dec 20087:03 amPRNDirectorate Change
5th Dec 20087:00 amPRNRe Contract
2nd Dec 20089:13 amPRNNotification of Trading Update
12th Nov 20087:30 amPRNBlock Listing
5th Nov 20087:00 amPRNInterim Management Statement
31st Oct 20088:55 amPRNTotal Voting Rights
28th Oct 20086:33 amPRNRe Contract
13th Oct 200810:42 amPRNHolding(s) in Company
6th Oct 20087:00 amPRNContract Win
30th Sep 20084:49 pmPRNHolding(s) in Company
22nd Sep 200810:53 amPRNHolding(s) in Company
19th Sep 20087:00 amPRNRe Contract
12th Sep 20083:08 pmPRNHolding(s) in Company
10th Sep 20081:50 pmPRNDirector/PDMR Shareholding
10th Sep 20081:00 pmPRNRe Contract
4th Sep 20081:44 pmPRNDoc re Half-Year Report
29th Aug 20082:21 pmPRNDoc re Half-Year Report
26th Aug 200811:49 amPRNCorrection : Director/PDMR Shareholding
21st Aug 200811:46 amPRNRe Contract
19th Aug 20085:09 pmPRNDirector/PDMR Shareholding
13th Aug 20087:06 amPRNRe Contract
13th Aug 20087:00 amPRNInterim Results
4th Aug 20087:00 amPRNContract
14th Jul 20087:00 amPRNRe Contract
9th Jul 20087:01 amPRNRe Contract
9th Jul 20087:00 amPRNTrading Statement
1st Jul 20089:50 amPRNBlocklisting - Interim Review
30th Jun 20082:40 pmPRNTotal Voting Rights
14th May 200812:12 pmPRNResult of AGM
14th May 20087:04 amPRNRe Contract
14th May 20087:00 amPRNInterim Management Statement
12th May 20084:50 pmPRNHolding(s) in Company
30th Apr 20081:24 pmPRNTotal Voting Rights
29th Apr 20082:51 pmPRNHolding(s) in Company
29th Apr 20089:02 amPRNAnnual Information Update
24th Apr 20088:56 amPRNDirector/PDMR Shareholding
22nd Apr 20087:00 amPRNAnalyst Event
21st Apr 200811:25 amPRNDirector/PDMR Shareholding
16th Apr 20085:07 pmPRNDirector/PDMR Shareholding
15th Apr 20082:02 pmPRNDirector/PDMR Shareholding
14th Apr 20084:39 pmPRNHolding(s) in Company
14th Apr 20081:51 pmPRNDirector/PDMR Shareholding
31st Mar 20081:39 pmPRNTotal Voting Rights
27th Mar 20087:00 amPRNRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.